A woman whose cancer has spread to her bones, back, pelvis and neck but has been denied a life-extending drug because she ...
The dose escalation portion of the trial enrolled patients with NSCLC to assess the safety and tolerability of datopotamab deruxtecan to determine the recommended dose for expansion (6 mg/kg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback